Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Talluto

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Anesthesia and Analgesia|March 4, 2025
Office-Based Anesthesia: An Update on Current Trends and PracticeJustin Talluto, Vikranth R Chinthareddy, Brian M Osman, et al.
International Anesthesiology Clinics|December 9, 2024
Office-Based Anesthesia Safety in 2024: Emergencies, Controversies, and Cognitive AidsJustin Talluto, Nicolette Duong, Brian Osman, et al.
Current Opinion in Anaesthesiology|June 10, 2025
2025 ISOBS OBA emergency manual: new drugs, devices, diversions, and dysfunctionJustin Talluto, Nicolette Duong, Vikranth R Chinthareddy, et al.
Pharmaceutics|February 27, 2026
<sup>89</sup>Zr-girentuximab PET/CT Enables Noninvasive Assessment of Indeterminate Renal Masses and Metastatic Clear-Cell Renal Cell CarcinomaYihan Cao, Jonathan Kim, Justin Talluto, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Anesthesia and Analgesia|March 4, 2025
Office-Based Anesthesia: An Update on Current Trends and PracticeJustin Talluto, Vikranth R Chinthareddy, Brian M Osman, et al.
International Anesthesiology Clinics|December 9, 2024
Office-Based Anesthesia Safety in 2024: Emergencies, Controversies, and Cognitive AidsJustin Talluto, Nicolette Duong, Brian Osman, et al.
Current Opinion in Anaesthesiology|June 10, 2025
2025 ISOBS OBA emergency manual: new drugs, devices, diversions, and dysfunctionJustin Talluto, Nicolette Duong, Vikranth R Chinthareddy, et al.
Pharmaceutics|February 27, 2026
<sup>89</sup>Zr-girentuximab PET/CT Enables Noninvasive Assessment of Indeterminate Renal Masses and Metastatic Clear-Cell Renal Cell CarcinomaYihan Cao, Jonathan Kim, Justin Talluto, et al.
Pageof 1